“Runner Up: Incidence of Cutaneous Adverse Events With PI3K-Akt-MTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 3, May 2022, p. s39, https://doi.org/10.25251/skin.6.supp.39.